Combination sclerostin antibody and zoledronic acid treatment outperforms either treatment alone in a mouse model of osteogenesis imperfecta
Keyword(s):
Keyword(s):
Keyword(s):
2011 ◽
Vol 75
(5)
◽
pp. 346-353
◽
2012 ◽
Vol 28
(1)
◽
pp. 73-80
◽
2015 ◽
Keyword(s):